Product
SimBioSys Wins FDA Clearance for Breast Cancer Recurrence AI Tool
SimBioSys has received FDA 510(k) clearance for TumorSight Risk, an AI software tool that uses breast MRI scans, pathology, and clinical data to estimate breast…
Research
#FDA clearance#breast cancer#healthcare AI#TumorSight Risk#AI#Announced